MASHdoc_SA said:If two explanations both fit, the useful question is which one predicts something the other does not.
Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.
robert_kc said:NASH/MAFLD therapeutic landscape and liver and MASH: GLP-1 agonists are emerging as potential first-line NASH therapy.
This answered a question I did not know how to ask.
MASHdoc_SA said:If two explanations both fit, the useful question is which one predicts something the other does not.
Pushing back on MASHdoc_SA here. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsAdding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.